Stelios Papadopoulos, Director at Regulus Therapeutics Inc. (RGLS), bought 1,000,000 shares at $0.91 ($910K) on 2017-07-25, disclosed to the SEC on 2017-07-25.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| EXEL | SELL | 2024-05-22 | $240K | — | Filing → |
| EXEL | SELL | 2022-02-24 | $3.3M | — | Filing → |
| EXEL | SELL | 2021-05-13 | $911K | — | Filing → |